Fresenius Medical Care Stock Fundamentals
| FMS Stock | USD 20.93 0.44 2.06% |
Fresenius Medical Care fundamentals help investors to digest information that contributes to Fresenius Medical's financial success or failures. It also enables traders to predict the movement of Fresenius Stock. The fundamental analysis module provides a way to measure Fresenius Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Fresenius Medical stock.
At this time, Fresenius Medical's Net Income is comparatively stable compared to the past year. Income Tax Expense is likely to gain to about 357.8 M in 2024, whereas Total Revenue is likely to drop slightly above 11.4 B in 2024. Fresenius | Select Account or Indicator |
Fresenius Medical Care Company Profit Margin Analysis
Fresenius Medical's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current Fresenius Medical Profit Margin | 0.03 % |
Most of Fresenius Medical's fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Fresenius Medical Care is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Fresenius Profit Margin Historical Pattern
Today, most investors in Fresenius Medical Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Fresenius Medical's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's profit margin growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Fresenius Medical profit margin as a starting point in their analysis.
Fresenius Medical Profit Margin |
| Timeline |
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
| Competition |
Fresenius Pretax Profit Margin
Pretax Profit Margin |
|
Based on the latest financial disclosure, Fresenius Medical Care has a Profit Margin of 0.0273%. This is 100.24% lower than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The profit margin for all United States stocks is 102.15% lower than that of the firm.
Fresenius Medical Care Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Fresenius Medical's current stock value. Our valuation model uses many indicators to compare Fresenius Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Fresenius Medical competition to find correlations between indicators driving Fresenius Medical's intrinsic value. More Info.Fresenius Medical Care is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers reporting about 0.57 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Fresenius Medical Care is roughly 1.74 . At this time, Fresenius Medical's Return On Equity is comparatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Fresenius Medical by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Fresenius Profit Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Fresenius Medical's direct or indirect competition against its Profit Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Fresenius Medical could also be used in its relative valuation, which is a method of valuing Fresenius Medical by comparing valuation metrics of similar companies.Fresenius Medical is currently under evaluation in profit margin category among its peers.
Fresenius Medical Current Valuation Drivers
We derive many important indicators used in calculating different scores of Fresenius Medical from analyzing Fresenius Medical's financial statements. These drivers represent accounts that assess Fresenius Medical's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Fresenius Medical's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 9.9B | 10.0B | 8.4B | 4.5B | 5.6B | 9.1B | |
| Enterprise Value | 22.7B | 21.3B | 20.2B | 16.4B | 16.3B | 13.9B |
Fresenius Medical ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Fresenius Medical's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Fresenius Medical's managers, analysts, and investors.Environmental | Governance | Social |
Fresenius Fundamentals
| Return On Equity | 0.0506 | ||||
| Return On Asset | 0.029 | ||||
| Profit Margin | 0.03 % | ||||
| Operating Margin | 0.08 % | ||||
| Current Valuation | 24.04 B | ||||
| Shares Outstanding | 586.83 M | ||||
| Shares Owned By Institutions | 7.00 % | ||||
| Number Of Shares Shorted | 683.32 K | ||||
| Price To Earning | 6.53 X | ||||
| Price To Book | 0.83 X | ||||
| Price To Sales | 0.65 X | ||||
| Revenue | 19.45 B | ||||
| Gross Profit | 5.31 B | ||||
| EBITDA | 3.44 B | ||||
| Net Income | 499 M | ||||
| Cash And Equivalents | 362.77 M | ||||
| Cash Per Share | 1.75 X | ||||
| Total Debt | 12.05 B | ||||
| Debt To Equity | 0.88 % | ||||
| Current Ratio | 1.18 X | ||||
| Book Value Per Share | 47.48 X | ||||
| Cash Flow From Operations | 2.63 B | ||||
| Short Ratio | 2.17 X | ||||
| Earnings Per Share | 0.98 X | ||||
| Price To Earnings To Growth | 0.44 X | ||||
| Target Price | 19.35 | ||||
| Number Of Employees | 113.64 K | ||||
| Beta | 0.86 | ||||
| Market Capitalization | 12.54 B | ||||
| Total Asset | 33.93 B | ||||
| Retained Earnings | 10.92 B | ||||
| Working Capital | 2.59 B | ||||
| Current Asset | 6.98 B | ||||
| Current Liabilities | 4.19 B | ||||
| Annual Yield | 0.03 % | ||||
| Five Year Return | 1.29 % | ||||
| Net Asset | 33.93 B | ||||
| Last Dividend Paid | 1.19 |
About Fresenius Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Fresenius Medical Care's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Fresenius Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Fresenius Medical Care based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 85.8 M | 81.5 M | |
| Total Revenue | 19.5 B | 11.4 B | |
| Cost Of Revenue | 14.5 B | 8 B | |
| Research And Ddevelopement To Revenue | 0.01 | 0.01 | |
| Capex To Revenue | 0.04 | 0.06 | |
| Revenue Per Share | 66.30 | 69.62 | |
| Ebit Per Revenue | 0.08 | 0.13 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Fresenius Stock Analysis
When running Fresenius Medical's price analysis, check to measure Fresenius Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fresenius Medical is operating at the current time. Most of Fresenius Medical's value examination focuses on studying past and present price action to predict the probability of Fresenius Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fresenius Medical's price. Additionally, you may evaluate how the addition of Fresenius Medical to your portfolios can decrease your overall portfolio volatility.